Concerns about AstraZeneca’s timeline arose this week with UK saying only 4 million doses of the Oxford-Astra shot would be available by the end of the year.
An initial interruption in AstraZeneca's vaccine trial in UK may have created a break in timeline, but has had little impact on the overall trial, putting it ahead of competitors.
AstraZeneca drug will be assessed for ability to avoid infections for as much as a year in some people & as a pre-emptive medicine once patients are exposed to the virus in others.
Covid-19 vaccines under development are injectable. Scientists are hoping for better immune responses with inhaled ones that directly target the nose & mouth.
The phase 1 and 2 trials resumed after the Japanese regulator gave the go-ahead. Trials in the UK, Brazil, South Africa and India had already restarted in recent weeks.
Sinovac, one of three Chinese vaccines in the last stages of testing, is expecting interim data as soon as November from its Phase 3 trial of almost 10,000 people in Brazil.
While bond yields tend to fall amid low inflation & interest rate cuts, market experts say they’ve been rising due to concerns over tax collections, fiscal deficit & potential impact of US tariffs.
It is one of the most advanced long-range air defence and anti-missile radars. It has been acquired under an about USD 145-million deal signed in 2020.
To be truly functional and durable, even eternal, a state doesn’t just need a leader, a party or an ideology. It needs functional and robust institutions.
COMMENTS